Literature DB >> 27512465

Monogenic diabetes and pregnancy.

Rinki Murphy1.   

Abstract

Monogenic diabetes is frequently mistakenly diagnosed as either type 1 or type 2 diabetes, yet accounts for approximately 1-2% of diabetes. Identifying monogenic forms of diabetes has practical implications for specific therapy, screening of family members and genetic counselling. The most common forms of monogenic diabetes are due to glucokinase (GCK), hepatocyte nuclear factor (HNF)-1A and HNF-4A, HNF-1B, m.3243A>G gene defects. Practical aspects of their recognition, diagnosis and management are outlined, particularly as they relate to pregnancy. This knowledge is important for all physicians managing diabetes in pregnancy, given this is a time when previously unrecognised monogenic diabetes may be uncovered with careful attention to atypical features of diabetes misclassified as type 1, type 2, or gestational diabetes.

Entities:  

Keywords:  Maturity-onset diabetes of the young (MODY); maternally inherited diabetes and deafness (MIDD); mitochondrial diabetes; monogenic diabetes

Year:  2015        PMID: 27512465      PMCID: PMC4935018          DOI: 10.1177/1753495X15590713

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  52 in total

1.  Searching for A3243G mitochondrial DNA mutation in buccal mucosa in order to improve the screening of patients with mitochondrial diabetes.

Authors:  H Narbonne; D Perucca-Lostanlen; C Desnuelle; B Vialettes; A Saunières; V Paquis-Flucklinger
Journal:  Eur J Endocrinol       Date:  2001-10       Impact factor: 6.664

2.  Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity.

Authors:  G Velho; A T Hattersley; P Froguel
Journal:  Diabetologia       Date:  2000-08       Impact factor: 10.122

3.  Predictive genetic testing in maturity-onset diabetes of the young (MODY).

Authors:  M Shepherd; I Ellis; A M Ahmad; P J Todd; D Bowen-Jones; G Mannion; S Ellard; A C Sparkes; A T Hattersley
Journal:  Diabet Med       Date:  2001-05       Impact factor: 4.359

4.  Contraindication of magnesium sulfate in a pregnancy complicated with late-onset diabetes mellitus and sensory deafness due to mitochondrial myopathy.

Authors:  T Hosono; M Suzuki; Y Chiba
Journal:  J Matern Fetal Med       Date:  2001-10

5.  The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria.

Authors:  C Bingham; S Ellard; A J Nicholls; C A Pennock; J Allen; A J James; S C Satchell; M B Salzmann; A T Hattersley
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

6.  HNF1alpha controls renal glucose reabsorption in mouse and man.

Authors:  M Pontoglio; D Prié; C Cheret; A Doyen; C Leroy; P Froguel; G Velho; M Yaniv; G Friedlander
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

7.  Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.

Authors:  E R Pearson; W G Liddell; M Shepherd; R J Corrall; A T Hattersley
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

8.  Influence of maternal and fetal glucokinase mutations in gestational diabetes.

Authors:  G Spyer; A T Hattersley; J E Sykes; R H Sturley; K M MacLeod
Journal:  Am J Obstet Gynecol       Date:  2001-07       Impact factor: 8.661

9.  A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria.

Authors:  S Ellard; F Beards; L I Allen; M Shepherd; E Ballantyne; R Harvey; A T Hattersley
Journal:  Diabetologia       Date:  2000-02       Impact factor: 10.122

10.  MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of "neonatal diabetes"?

Authors:  F Prisco; D Iafusco; A Franzese; N Sulli; F Barbetti
Journal:  Diabetologia       Date:  2000-10       Impact factor: 10.122

View more
  3 in total

Review 1.  The Challenges of Treating Glucokinase MODY during Pregnancy: A Review of Maternal and Fetal Outcomes.

Authors:  Alena Kirzhner; Oren Barak; Edi Vaisbuch; Taiba Zornitzki; Tal Schiller
Journal:  Int J Environ Res Public Health       Date:  2022-05-14       Impact factor: 4.614

Review 2.  The Human Islet: Mini-Organ With Mega-Impact.

Authors:  John T Walker; Diane C Saunders; Marcela Brissova; Alvin C Powers
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 25.261

3.  Pregnancy Complicated by Maternal MODY 3 and Paternal MODY 2 Diabetes and Subsequent Rapidly Falling Insulin Requirement.

Authors:  Anastasia Mikuscheva; Adel Mekhail; Benjamin J Wheeler
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.